GIC receives govt funding for immuno-oncology project
World | News | 0 Comment | 22 Aug, 2018
Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Counci...Read more
World | News | 0 Comment | 21 Aug, 2018
Singapore - Achillion Pharmaceuticals appoints Steven Zelenkofske, D.O. to the position of Executive Vice President...Read more
Researchers develop predictor for immunotherapy response in melanoma
World | News | 0 Comment | 21 Aug, 2018
In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patie...Read more
FDA grants orphan drug status to ASLAN’s treatment for AML
World | News | 0 Comment | 20 Aug, 2018
Singapore - ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly pre...Read more
Tolero Pharmaceuticals collaborates with AbbVie for AML trial
World | News | 0 Comment | 20 Aug, 2018
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...Read more
Verana Health Announces $30M Series C Financing
World | News | 0 Comment | 20 Aug, 2018
Verana Health, the developer of a cutting-edge platform for life science innovation that utilizes regulatory-grade speci...Read more
FDA approves first generic version of EpiPen
World | News | 1 Comment | 17 Aug, 2018
The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-...Read more
Scientists develop platform to kill cancer cells
World | News | 0 Comment | 17 Aug, 2018
An interdisciplinary group of scientists from NUST MISIS, Lomonosov Moscow State University, Pirogov Russian National Re...Read more
Dr Sundar receives an honor of first female President of BGCS
World | News | 0 Comment | 16 Aug, 2018
University of Birmingham women’s cancer expert Dr Sudha Sundar has been chosen as the President-Elect of the Briti...Read more
rfxcel enhances Pharmaceutical Track and Trace Solution for Russia
World | News | 0 Comment | 16 Aug, 2018
rfxcel, the global leader in track and trace solutions, releases enhancements to its compliance solution for Russia and ...Read more
Multi- institutional alliance to develop anti-aging drugs
World | News | 0 Comment | 16 Aug, 2018
The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial int...Read more
Mylan brings first generic for Adcirca tablets
World | News | 0 Comment | 14 Aug, 2018
Global pharmaceutical company Mylan N.V. has announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the f...Read more
Orchard Therapeutics raises $150 M to improve Gene Therapy Pipeline
World | News | 0 Comment | 13 Aug, 2018
Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare disea...Read more
Researchers develop AI technique to treat cancer
World | News | 0 Comment | 13 Aug, 2018
MIT researchers, including one of Indian-origin, have developed novel machine-learning techniques to improve the quality...Read more
FDA approves Amicus' Galafold for Fabry disease
World | News | 0 Comment | 13 Aug, 2018
Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medicati...Read more
Artios Pharma announces $84 M Series B financing
World | News | 0 Comment | 13 Aug, 2018
Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing innovative treatments for cancer ...Read more
Astellas acquires Quethera for up to £85M
World | News | 0 Comment | 10 Aug, 2018
Singapore- Astellas Pharma and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company he...Read more
OncoCyte appoints Albert P. Parker as COO
World | News | 0 Comment | 10 Aug, 2018
Singapore- OncoCyte Corporation, a developer of novel, non-invasive liquid biopsy tests for the early detection of cance...Read more